Skip to main content
Equibles
ACTU logo

ACTU · Actuate Therapeutics, Inc. · Proposed Sales

Track ACTU — free

Use ACTU with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACTU.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.30 +0.01 (+1.75%) At close · Nov 11
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Based on the above matters, we have concluded that there is substantial doubt regarding the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$7.26M
Shares
24.01M
Volume · Nov 11 94.93K Avg daily vol (3M) 422.63K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-12-11 Kairos Venture Partners II, L.P. 280,000
Showing 1–1 of 1 filings
Key facts CIK 1652935 CUSIP 005083100 13F (30d) 18 filings 18 filers Visit website Investor relations